Please take part in our global surveys! Imperial Psychedelic Research Group are proud to launch three new exciting surveys into the use of Psychedelics. Please visit either The Psychedelic Ceremony Study, The Global Psychedelic Survey or The Microdosing Survey Study.
Patients taking psilocybin to treat depression show reduced symptoms weeks after treatment following a ‘reset’ of their brain activity. … The findings come from a study in which researchers from Imperial College London used psilocybin – the
This study was approved by the National Research Ethics Service (NRES) committee London – West London and was conducted in accordance with the revised declaration of Helsinki (2000), the International Committee on Harmonisation Good Clinical Practice (GCP) guidelines and National
Infographic: The Brain on Psychedelics Understanding how hallucinogenic drugs affect different neural networks could shed light on their therapeutic potential. © CATHERINE DELPHIAKey brain areas involved in the effects of psychedelic drugs are located in the default mode network (DMN),
© SEAN MCCABE Lying in a room at Imperial College London, surrounded by low lighting and music, Kirk experienced a vivid recollection of visiting his sick mother before she passed away. “I used to go and see my mum in
Could psychedelic drugs make the world a better place? In this talk, Robin Carhart-Harris will describe the rationale behind conducting the first ever clinical trial of psilocybin (magic mushrooms) as a treatment for depression – and share his results. Robin